Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine.

导出 LinkOut

翻译打印收藏纠错

作者： Carlo,Pescia ^[1] ; Francesca,Boggio ^[2] ; Giorgio Alberto,Croci ^[1] ; Ramona,Cassin ^[1] ; Marco,Barella ^[2] ; Loredana,Pettine ^[3] ; Gianluigi,Reda ^[1] ; Elena,Sabattini ^[2] ; Carlo,Finelli ^[3] ; Umberto,Gianelli ^[3]

作者单位： Division of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy. ^[1] Department of Pathophysiology and Transplantation, Università degli studi di Milano, 20122 Milan, Italy. ^[2] Division of Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy. ^[3] Hematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. ^[4] Division of Hematology "Seràgnoli", IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. ^[5]

关键词 azacitidine bone marrow histology myelodysplastic syndromes

DOI 10.3390/jcm10214809

PMID 34768330

发布时间 2021-11-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical medicine

2021年10卷21期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

检索历史清除